reference/27151214

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27151214

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	141
issn	1499-2752 0315-162X
issueIdentifier	2
pageRange	133-141
publicationName	The Journal of Rheumatology
startingPage	133
bibliographicCitation	van der Heijde D, Kartman CE, Xie L, Beattie S, Schlichting D, Mo D, Durez P, Tanaka Y, Fleischmann R. Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND. J Rheumatol. 2022 Feb;49(2):133–41. doi: 10.3899/jrheum.210346. PMID: 34526397.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbd096a9bdcfa45fc1a0cacbd0a3e395 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c7fff423ad6cc433401e2a28c8f6292 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edc40117d6b92ad96d95ee9cb5910fff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1447a824f98d0057ff946c3de13bb4d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c59f1ed3e222e7e241d0c5e73d98d850 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2710-1234 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1093ed8fb84e8c919dac8b22f9f013e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93170d93f466412f47db9a85990f80b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eaaeb6749b1c7d192e3400f81905cc28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bc86eb1128bc494121d6e7003b88b70
date	2021-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/34526397 https://doi.org/10.3899/jrheum.210346
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5243 https://portal.issn.org/resource/ISSN/1499-2752 https://portal.issn.org/resource/ISSN/0315-162X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND
discusses	http://id.nlm.nih.gov/mesh/M0018169 http://id.nlm.nih.gov/mesh/M0013595 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M000603439 http://id.nlm.nih.gov/mesh/M0002072 http://id.nlm.nih.gov/mesh/M0422769 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0027742
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001172Q000188 http://id.nlm.nih.gov/mesh/D001172Q000000981 http://id.nlm.nih.gov/mesh/D018501Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D013449 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011687 http://id.nlm.nih.gov/mesh/D000068879Q000627 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D001384 http://id.nlm.nih.gov/mesh/D008727Q000627 http://id.nlm.nih.gov/mesh/D011720
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44205240

Total number of triples: 54.